Brief: Unicycive Therapeutics Received A Notice From Nasdaq That Co Is Not In Compliance With $1.00 Minimum Bid Price Requirement
25/09/2023 21:17
Sept 25 (Reuters) - Unicycive Therapeutics Inc UNCY.O :
* UNICYCIVE THERAPEUTICS INC: ON SEPT 19, CO RECEIVED A
NOTICE
FROM NASDAQ THAT CO IS NOT IN COMPLIANCE WITH $1.00 MINIMUM BID
PRICE REQUIREMENT
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss